Stock listing
TPEx:4183 EPS Bio Technology Corp. (福永生技) 股價
Follow EPS Bio Technology Corp. into a list and get an email when it puts out news.
Share price · TPEX:4183
$13.25 TWD -1.25 (-8.6%)
Close on Nov 20, 2026
- Day range
- $13.20 – $13.80 TWDNov 20, 2026
- Volume
- 28,001 sharesNov 20, 2026
- Market cap
- $315.4M TWDAt the close on Nov 20, 2026 · price × 23.80M shares outstanding
- 52-week range
- $11.60 – $17.55 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $85,087 TWDMedian day 2,000 shares · 20 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:4183 · TWD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $13.25 | -1.25 | -8.6% | $13.60 | $13.80 | $13.20 | 28,001 | |
| $14.50 | 0.00 | 0.0% | $14.40 | $14.50 | $14.40 | 6,000 | |
| $14.50 | +0.10 | +0.7% | $13.75 | $14.50 | $13.75 | 24,000 | |
| $14.40 | 0.00 | 0.0% | $14.25 | $14.40 | $14.25 | 7,000 | |
| $14.40 | 0.00 | 0.0% | $13.40 | $14.50 | $13.40 | 11,000 | |
| $14.40 | -0.10 | -0.7% | $14.40 | $14.40 | $14.40 | 7,000 | |
| $14.50 | 0.00 | 0.0% | $14.45 | $14.50 | $14.45 | 6,000 | |
| $14.50 | +0.10 | +0.7% | $14.50 | $14.50 | $14.40 | 14,000 | |
| $14.40 | 0.00 | 0.0% | $14.40 | $14.40 | $14.40 | 0 | |
| $14.40 | 0.00 | 0.0% | $14.40 | $14.40 | $14.40 | 0 | |
| $14.40 | 0.00 | 0.0% | $14.40 | $14.40 | $14.40 | 9,114 | |
| $14.40 | 0.00 | 0.0% | $14.35 | $14.40 | $14.35 | 12,114 | |
| $14.40 | 0.00 | 0.0% | $14.40 | $14.40 | $14.40 | 0 | |
| $14.40 | 0.00 | 0.0% | $14.40 | $14.40 | $14.40 | 2,000 | |
| $14.40 | +0.35 | +2.5% | $14.40 | $14.40 | $14.40 | 1,000 | |
| $14.05 | -0.45 | -3.1% | $14.50 | $14.55 | $14.05 | 7,000 | |
| $14.50 | +0.90 | +6.6% | $13.60 | $14.50 | $13.60 | 13,000 | |
| $13.60 | -0.70 | -4.9% | $13.20 | $13.60 | $13.15 | 11,000 | |
| $14.30 | 0.00 | 0.0% | $14.30 | $14.30 | $14.30 | 0 | |
| $14.30 | +0.10 | +0.7% | $14.85 | $15.35 | $14.25 | 20,254 | |
| $14.20 | 0.00 | 0.0% | $14.20 | $14.20 | $14.20 | 0 | |
| $14.20 | 0.00 | 0.0% | $14.20 | $14.20 | $14.20 | 0 | |
| $14.20 | 0.00 | 0.0% | $14.20 | $14.20 | $14.20 | 0 | |
| $14.20 | 0.00 | 0.0% | $14.20 | $14.20 | $14.20 | 1,010 | |
| $14.20 | -0.40 | -2.7% | $14.20 | $14.20 | $14.20 | 1,000 | |
| $14.60 | 0.00 | 0.0% | $14.60 | $14.60 | $14.60 | 0 | |
| $14.60 | -0.15 | -1.0% | $13.75 | $14.60 | $13.75 | 3,001 | |
| $14.75 | 0.00 | 0.0% | $14.75 | $14.75 | $14.75 | 0 | |
| $14.75 | 0.00 | 0.0% | $14.75 | $14.75 | $14.75 | 0 | |
| $14.75 | 0.00 | 0.0% | $14.75 | $14.75 | $14.75 | 0 | |
| $14.75 | 0.00 | 0.0% | $14.75 | $14.75 | $14.75 | 0 | |
| $14.75 | +0.40 | +2.8% | $14.75 | $14.75 | $14.75 | 1,000 | |
| $14.35 | -0.10 | -0.7% | $14.35 | $14.35 | $14.35 | 3,000 | |
| $14.45 | +0.90 | +6.6% | $14.00 | $14.45 | $14.00 | 7,041 | |
| $13.55 | -0.40 | -2.9% | $13.90 | $13.95 | $13.55 | 3,000 | |
| $13.95 | +0.65 | +4.9% | $13.30 | $13.95 | $13.30 | 7,000 | |
| $13.30 | -0.95 | -6.7% | $13.30 | $13.30 | $13.30 | 14,000 | |
| $14.25 | +0.60 | +4.4% | $13.85 | $14.25 | $13.85 | 16,000 | |
| $13.65 | -0.70 | -4.9% | $14.35 | $14.35 | $13.65 | 21,004 | |
| $14.35 | +1.30 | +10.0% | $13.50 | $14.35 | $13.50 | 61,000 | |
| $13.05 | 0.00 | 0.0% | $13.00 | $13.05 | $13.00 | 8,000 | |
| $13.05 | 0.00 | 0.0% | $13.30 | $13.30 | $13.05 | 2,000 | |
| $13.05 | -0.15 | -1.1% | $13.00 | $13.05 | $13.00 | 2,000 | |
| $13.20 | -0.30 | -2.2% | $13.20 | $13.20 | $13.20 | 1,000 | |
| $13.50 | 0.00 | 0.0% | $13.50 | $13.50 | $13.20 | 3,000 | |
| $13.50 | -0.70 | -4.9% | $13.35 | $13.50 | $13.35 | 3,000 | |
| $14.20 | 0.00 | 0.0% | $14.20 | $14.20 | $14.20 | 0 | |
| $14.20 | 0.00 | 0.0% | $14.20 | $14.20 | $14.20 | 0 | |
| $14.20 | 0.00 | 0.0% | $14.20 | $14.20 | $14.20 | 0 | |
| $14.20 | 0.00 | 0.0% | $14.20 | $14.20 | $14.20 | 0 | |
| $14.20 | +0.20 | +1.4% | $14.20 | $14.20 | $14.20 | 2,005 | |
| $14.00 | 0.00 | 0.0% | $14.00 | $14.00 | $14.00 | 0 | |
| $14.00 | 0.00 | 0.0% | $14.00 | $14.00 | $14.00 | 1,000 | |
| $14.00 | 0.00 | 0.0% | $14.00 | $14.00 | $14.00 | 1,000 | |
| $14.00 | 0.00 | 0.0% | $14.00 | $14.00 | $14.00 | 0 | |
| $14.00 | 0.00 | 0.0% | $14.00 | $14.00 | $14.00 | 2,000 | |
| $14.00 | +0.30 | +2.2% | $13.50 | $14.00 | $13.50 | 19,000 | |
| $13.70 | -0.50 | -3.5% | $13.70 | $13.70 | $13.70 | 1,039 | |
| $14.20 | 0.00 | 0.0% | $14.20 | $14.20 | $14.20 | 0 | |
| $14.20 | +0.20 | +1.4% | $13.55 | $14.20 | $13.55 | 2,005 | |
| $14.00 | 0.00 | 0.0% | $14.00 | $14.00 | $14.00 | 0 | |
| $14.00 | -0.10 | -0.7% | $14.50 | $14.60 | $14.00 | 11,000 |
Splits
1 split · TPEX:4183 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 26-for-25 | Split |
- Ticker
- TPEx:4183
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- TPEx
- Currency
- TWD
Latest news
EPS Bio Technology Corp. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 5 in all · newest Aug 4, 2022 · oldest 2022
Valuation
EV/sales 0.4× against a median of 8.6×: 3rd lowest of 9 Medical devices & supplies companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $190.2M TWD
- P/E
- Loss
- EV/sales
- 0.4×
- EV/EBITDA
- 21.4×
- Price/book
- 1.2×
- Gross margin
- 17.4%
- Operating margin
- −1.3%
- Net margin
- −1.6%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| EPS Bio Technology Corp. · TPEX:4183 | US$9.57M | US$5.77M | n/a | 0.4× | 21.4× | 1.2× | −1.6% | 0.0× | n/a |
| Femasys Inc. · NASDAQ:FEMY | US$10.73M | −US$8.31M | n/a | −4.2× | n/a | 0.4× | −614.7% | 0.2× | 1.60 |
| ADM Tronics Unlimited, Inc. · OTC:ADMT | US$9.97M | US$9.77M | n/a | 3.0× | n/a | 13.4× | −4.3% | 0.0× | -1.45 |
| United Health Products, Inc. · OTC:UEEC | US$9.69M | US$9.69M | n/a | n/a | n/a | n/a | n/a | n/a | -0.09 |
| Guided Therapeutics, Inc. · OTC:GTHP | US$9.65M | US$9.68M | n/a | 14.2× | n/a | n/a | −445.9% | n/a | -0.75 |
| Nestmedic SA · NEWCONNECT:NST | US$9.65M | US$9.24M | n/a | 38.8× | n/a | 3.2× | −413.6% | 0.0× | n/a |
| VVT Med Inc. · TSXV:VVTM | US$8.99M | US$8.99M | n/a | 93.6× | n/a | n/a | n/a | n/a | 1.16 |
| SpineGuard · EURONEXT:ALSGD | US$8.88M | US$9.65M | n/a | 2.3× | n/a | 1.8× | −55.0% | 0.3× | n/a |
| Pulsenmore Ltd. · TASE:PLSM | US$8.71M | US$2.27M | n/a | 0.2× | n/a | 0.3× | −39.6% | 0.0× | n/a |
| Conavi Medical Corp. · TSXV:CNVI | US$8.66M | US$8.89M | n/a | 15.1× | n/a | n/a | n/a | n/a | 0.36 |
| Allmed Solutions Ltd. · TASE:ALMD | US$8.42M | US$1.41M | n/a | n/a | n/a | 1.4× | n/a | 0.0× | n/a |
| Median of the others | US$9.32M | US$9.11M | 8.6× | 1.6× | −234.3% | 0.0× | 0.14 |
Financials
Annual, in TWD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 499.7M | 451.1M | 470.2M | 463.5M | 480.3M | 477.6M | 459.3M |
| Cost of revenue | 412.7M | 354.8M | 354.5M | 356.0M | 359.6M | 342.8M | 348.1M |
| Gross profit | 87.0M | 96.3M | 115.7M | 107.4M | 120.7M | 134.8M | 111.3M |
| Research and development | 34.5M | 33.4M | 33.2M | 30.9M | 32.3M | 30.4M | 30.9M |
| Selling, general and administrative | 59.0M | 41.8M | 42.5M | 40.6M | 37.9M | 41.3M | |
| Operating income | -6.50M | 3.51M | 24.9M | 32.2M | 26.9M | 43.6M | 27.7M |
| Depreciation and amortization | 15.4M | 14.6M | 15.5M | 17.3M | 18.6M | 17.8M | 15.7M |
| EBITDA | 8.88M | 18.1M | 40.4M | 49.5M | 45.5M | 61.5M | 43.4M |
| Interest expense | 1.90M | 2.05M | 2.13M | 2.13M | 2.18M | 2.29M | 2.53M |
| Income before tax | -9.67M | 17.8M | 26.5M | 27.5M | 23.5M | 40.1M | 24.0M |
| Income tax | 499.0K | 5.47M | 2.10M | 4.88M | 8.37M | 5.57M | |
| Net income | -7.87M | 17.3M | 21.0M | 25.4M | 18.6M | 31.7M | 18.4M |
| Earnings per share, basic | -0.33 | 0.73 | 0.88 | 1.06 | 0.78 | 1.33 | 0.77 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 123.1M | 128.9M | 195.3M | 178.7M | 203.4M | 221.9M | 175.8M |
| Receivables | 150.4M | 153.6M | 92.1M | 78.8M | 101.2M | 80.5M | 105.9M |
| Inventory | 73.2M | 81.1M | 72.7M | 86.4M | 81.6M | 49.3M | 47.3M |
| Current assets | 355.5M | 368.0M | 366.3M | 347.8M | 393.1M | 355.3M | 333.0M |
| Total assets | 533.2M | 541.9M | 543.2M | 527.8M | 577.5M | 547.0M | 534.6M |
| Accounts payable | 72.7M | 80.6M | 74.5M | 58.3M | 81.4M | 56.6M | 62.5M |
| Current liabilities | 154.6M | 129.8M | 125.0M | 103.3M | 157.2M | 111.3M | 108.7M |
| Long-term debt | 7.76M | 10.4M | 13.0M | 15.5M | 18.0M | ||
| Total debt | 110.1M | 115.8M | 121.4M | 126.5M | 131.9M | 28.4M | |
| Total liabilities | 252.1M | 237.3M | 237.1M | 219.4M | 278.2M | 237.8M | 240.5M |
| Shareholders' equity | 281.1M | 304.6M | 306.0M | 308.4M | 299.3M | 309.2M | 294.1M |
| Shares outstanding | 23.8M | 23.9M | 23.9M | 23.9M | 23.9M | 23.9M | 23.9M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash from operations | 603.0K | -32.3M | 55.2M | 5.00M | 32.1M | 79.9M | 21.8M |
| Capital spending | -24.0M | -14.4M | -9.48M | -15.0M | -12.1M | -6.98M | -15.2M |
| Free cash flow | -23.4M | -46.7M | 45.7M | -9.96M | 19.9M | 72.9M | 6.69M |
| Cash from financing | -24.7M | -28.9M | -22.6M | -34.0M | -22.0M | -21.8M | |
| Dividends paid | -15.9M | -19.0M | -23.3M | -16.7M | -28.6M | -16.7M | -16.7M |
| Change in cash | -5.86M | -66.3M | 16.6M | -24.8M | -18.5M | 46.1M | -19.0M |
Cap table
Built by 6ix from EPS Bio Technology Corp.’s releases
- Common shares
- 23,800,000
- Fully diluted
- 23,800,000
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 23,800,000 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 23,800,000 |
Log in to ask 6ix AI your own questions about EPS Bio Technology Corp.